Description: Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names. It also offers medicines for various therapeutic comprising gynaecology, pediatrics, dermatology, and other generic medicines under the Anin, Suprox, Cozy, Distone, and Oliade name. In addition, the company provides antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial, anti-depressants, cardiology, diabetology, anti-depressant, anti-allergic, anti- infective, neurology, and oncology. Ind-Swift Limited provides Ayurvedic products, as well as contract research and manufacturing services. The company exports its products, as well as licenses its products to Europe, Australia, Canada, South Africa, and Russia. Swift Limited was founded in 1983 and is based in Chandigarh, India.
Home Page: www.indswiftltd.com
781, Industrial Area
Chandigarh,
160002
India
Phone:
91 17 2263 8781
Officers
| Name | Title |
|---|---|
| Mr. Sanjeev Rai Mehta BSc | Executive Chairman |
| Dr. Gopal Munjal M.D. | CEO, MD & Whole Time Director |
| Dr. Vikrant Rai Mehta M.Sc | Joint MD & Whole Time Director |
| Mr. Arun K. Seth | CFO & GM of Finance & Accounts |
| Mr. Ravi Kumar Bhardwaj | Vice President of Operations |
| Ms. Annie Mehta | Head of Administration |
| Mr. Rajinder Kumar Gupta | Associate Vice President of Marketing |
| Mr. Om Prakash Thapliyal | Vice President of Human Resources |
| Ms. Suchitra Bhatnagar | Associate Vice President of Quality |
| Mr. Sudhir Sethi | Senior General Manager of Purchase |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 2.6755 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.3143 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1054 |